Alliance for Cancer Gene Therapy Inc
ACGT SUPPORTS HIGH-RISK, HIGH-REWARD SCIENTIFIC RESEARCH TO DEVELOP CANCER THERAPEUTICS THAT USE THE BODY'S OWN CELLS AND GENES AS A LIVING MEDICINE. BY ACCELERATING THIS RESEARCH, ACGT IS HELPING TO ADVANCE THERAPIES THAT ARE SIGNIFICANTLY MORE EFFECTIVE AND LESS TOXIC THAN CURRENT CANCER TREATMENTS SUCH AS CHEMOTHERAPY AND RADIATION.
Financial Overview
From 2025 IRS Form 990-PF
Total Assets
$15.7M
+4.6% YoY
Annual Giving
$4.3M
Grant Count
5
Avg Grant Size
$866K
Go deeper than public filings
PRO- Giving trend analysis — growing or declining?
- Organizations like yours that won grants here
- Strategic fit assessment for your organization
- Application timing recommendations
Financial History
Multi-year comparison from IRS filings
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $15,733,028 | $15,042,870 | $7,929,383 |
| Revenue | $3,103,520 | $9,059,178 | $3,231,770 |
| Expenses | $5,355,546 | $1,966,204 | $2,498,579 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $917,192 | $294,442 | $435,133 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 5 recipients in 2025
Grant Size Distribution
13 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for .
Who else does Alliance for Cancer Gene Therapy Inc fund?
Explore the funder–grantee relationships behind this foundation, powered by GrantGraph™ — our database of 11 million+ funding connections.
- Similar orgs that won grants here
- GrantGraph™ relationship mapping
- 11M+ connections in GrantGraph™
Key People
Officers and directors from IRS filings
Compensation Overview
From 2025 IRS filing
From 2025 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| KEVIN HONEYCUTT | CEO & PRESIDENT | 40 | — |
| MARC ENGELSGJERD MD | DIRECTOR (EFF 12/5/24) | 1 | — |
| DANIEL ENGLANDER | DIRECTOR | 1 | — |
| MARIA FARDIS PHD | DIRECTOR | 1 | — |
| PETER A GLICKLICH ESQ | DIRECTOR | 1 | — |
| MICHAEL GREGORY | DIRECTOR | 1 | — |
| CHAU Q KHUONG | DIRECTOR | 1 | — |
| JOHN LAHEY PHD | DIRECTOR | 1 | — |
| ALEXANDRA LANDES | DIRECTOR | 1 | — |
| BRUCE L LEVINE PHD | DIRECTOR | 1 | — |
| BARBARA NETTER | DIRECTOR, HONORARY CHAIRMAN | 6 | — |
| CHEN SCHOR | DIRECTOR | 1 | — |
| JOHN C SITES JR | DIRECTOR | 1 | — |
| KLAUS R VEITINGER MD PHD | DIRECTOR | 1 | — |
| MARTIN E WINTER | DIRECTOR | 1 | — |
| GBOLA AMUSA | DIRECTOR (THRU 6/27/24) | 1 | — |
| THERESA BURGESS PHD | DIRECTOR (THRU 6/27/24) | 1 | — |
| H WILLIAM SMITH | VICE PRESIDENT, LEGAL & SECRETARY | 2 | — |
| CHRISTINE HERMAN | VICE PRESIDENT, TREAS(THRU 5/31/25) | 2 | — |
| BARBARA LAVERY | CHIEF PROGRAM OFFICER | 40 | $264,230 |
| KERI EISENBERG | CHIEF PHILANTHROPY OFFICER | 40 | $215,301 |
Geographic Focus
Where this funder has awarded grants
Grant Distribution by State
Cities
Data last updated March 2026. Sourced from IRS Form 990-PF filings.
What could you do with Alliance for Cancer Gene Therapy Inc on Grantable?
- Assess strategic fit with your organization
- Get AI-generated opportunity briefs
- Monitor for new funding opportunities
- Draft a tailored letter of inquiry